Rastogi S C, Clausen J
Acta Neurol Scand. 1983 Apr;67(4):218-21. doi: 10.1111/j.1600-0404.1983.tb04566.x.
The effects of factors secreted by polymorphonuclear leucocytes (PMNL) incubated with multiple sclerosis (MS) and control brain antigens (MSG2 and KG2 respectively) were evaluated by assay of thymidine uptake by lymphocytes from normal individuals and MS patients. It was found that the cellular uptake of thymidine of both MS and normals was significantly lower in the presence of MSG2-PMNL supernatants compared to that in the presence of KG2-PMNL or without antigen-PMNL supernatant. The findings indicate that an inhibitor of lymphocyte proliferation either may be released from PMNL by the action of MSG2 or may be synthesized in response to challenge by MSG2.
通过检测来自正常个体和多发性硬化症(MS)患者淋巴细胞的胸苷摄取量,评估了与多发性硬化症(MS)脑抗原和对照脑抗原(分别为MSG2和KG2)一起孵育的多形核白细胞(PMNL)分泌因子的作用。结果发现,与存在KG2 - PMNL或无抗原 - PMNL上清液相比,在存在MSG2 - PMNL上清液的情况下,MS患者和正常人的淋巴细胞对胸苷的细胞摄取量均显著降低。这些发现表明,淋巴细胞增殖抑制剂可能是由MSG2作用从PMNL释放出来的,或者可能是在受到MSG2刺激后合成的。